PROMISE Theme
@promise-theme.bsky.social
PROMISE’s mission is to create a community focused on pediatric, adolescent and young adult oncology to accelerate research and disseminate discoveries that will improve outcomes for patients living with cancer in Manitoba and their loved ones.
Registration is now open for the 2nd PROMISE Research Day! Join us Sept 23, 2026, at CancerCare Manitoba for a day of pediatric oncology research, innovation, and collaboration. Abstract deadlines: • Oral & Rapid-Fire: Aug 2 • Poster Only: Aug 23 Register: forms.gle/59Afgf8qaCfF... #CCMB #CHRIM
📢 Deadline Extended! There's still time to submit your abstract for an Oral Presentation or Rapid-Fire Presentation at the 2nd PROMISE Research Day! 🗓️ New submission deadline: August 2, 2026 Submit your abstract before the new deadline! #PediatricCancer #AYACancer #CHRIM #CCMB #Elsevier
Congratulations to PROMISE Co-PI @brittdrog.bsky.social on receiving a CIHR Project Grant! 👏 #PROMISE #CHRIM #CIHR
Biochemistry & Medical Genetics@umbmg.bsky.social · 2w agoHuge congrats to Britt Drögemöller for receiving a CIHR Project Grant and supplemental funding through the Maud Menten New Principal Investigator Prizes in Genetics 👏 👏 👏 Read more about this exciting project here: lnkd.in/gNAtfChR
📢 The abstract submission deadline for oral presentations and rapid-fire presentations at the 2nd PROMISE Research Day is July 23, 2026! Don’t miss this opportunity to showcase your research, Submit your abstract today! #PROMISEResearchDay #CancerResearch #PediatricCancer #CHRIM #CCMB
PROMISE Theme@promise-theme.bsky.social · last mo.📢 Call for Abstracts – 2nd PROMISE Research Day 📚✨ 🏆 Presentation Awards • $400 – Best 2 Oral Presentations • $300 – Top 3 Rapid-Fire Presentations • $200 – Top 3 Poster Presentations 📅 Submission Deadline: July 23, 2026 📧 Submit your abstract: promise@umanitoba.ca #CHRIM #CCMB #CancerResearch
Congratulations to PROMISE lead PI Dr. @cedricstremblay.bsky.social on receiving a Canadian Cancer Society Emerging Scholar Research grant valued at $550,000 over 5 years. #CHRIM #CCMB #CancerResearch #AYACAN
CancerCare Manitoba@cancercaremb.bsky.social · 3w agoCongratulations to Dr. @cedricstremblay.bsky.social on receiving a Canadian Cancer Society Emerging Scholar Research grant valued at $550,000 over 5 years. His research will investigate why leukemia returns after treatment by studying the cancer cells that survive chemotherapy.
HIRING: Graduate Student! The #TremblayLab is looking for a motivated trainee to join the Department of Immunology, Univ of Manitoba! The Focus: Developing cutting-edge genetic tools to study hematopoietic stem cells and leukemia. Start: January /May 2027 #CCMB #CHRIM www.tremblaylab.com/team
Team & Engagement | Tremblay Lab
We are a passionate team of multidisciplinary experts aiming to positively impact lives of people living with acute leukemia
tremblaylab.com
📢 Publication alert! Congratulations to PROMISE Co-PI Dr. Sapna Oberoi and colleagues on their latest publication: Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on the Children's Oncology Group ARST0332 trial. academic.oup.com/jnci/advance...
Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children’s oncology group ARST0332 trial
AbstractBackground. We evaluated clinical characteristics, response to therapy, event-free and overall survival (EFS and OS), patterns of recurrence/progre
academic.oup.com
Please share widely with your networks: Research Manitoba is currently accepting proposals for Indigenous research ethics and framework consulting. Proposals are due August 10. https://researchmanitoba.ca/research-manitoba-request-for-proposals-indigenous-research-framework-and-ethics-consultant/
Research Manitoba Request for Proposals: Indigenous Research Framework and Ethics Consultant - Research Manitoba
researchmanitoba.ca
🚨 Publication Alert! Congratulations to Ovini Amarasinghe on her first first-author publication: Enhancing CAR-NK persistence to unlock its full therapeutic potentials. in collaboration with Heqing Ma, with the guidance of NK cell expert Dr. Sam Kung. #CCMB #CHRIM @um-radyfhs.bsky.social
Frontiers | Enhancing CAR-NK persistence to unlock its full therapeutic potentials
Chimeric Antigen Receptor-Natural Killer Cell (CAR-NK) is a promising next-generation immunotherapy. Persistence of CAR-NK cell therapy is considered a key h...
frontiersin.org
📢 Call for Abstracts – 2nd PROMISE Research Day 📚✨ 🏆 Presentation Awards • $400 – Best 2 Oral Presentations • $300 – Top 3 Rapid-Fire Presentations • $200 – Top 3 Poster Presentations 📅 Submission Deadline: July 23, 2026 📧 Submit your abstract: promise@umanitoba.ca #CHRIM #CCMB #CancerResearch
June is #PrideMonth. At ACCESS, we believe that improving pediatric cancer outcomes starts with including everyone. Equity isn't just a value we hold. It's a shared responsibility because EVERY child deserves access to the best possible care, regardless of who they are or where they come from. #EDI
Congratulations to PROMISE PI Dr. Cedric Tremblay and other co-authors on their new publication: LYL1 is critical for adult hematopoietic stem cell-derived B and T lymphopoiesis: www.nature.com/articles/s41...
LYL1 is critical for adult hematopoietic stem cell-derived B and T lymphopoiesis - Scientific Reports
Scientific Reports - LYL1 is critical for adult hematopoietic stem cell-derived B and T lymphopoiesis
nature.com
ACCESS Summer Research Experience 2026 Are you a student or trainee working in pediatric cancer research? Join an educational program for trainees involved in pediatric cancer research across Canada. ubc.ca1.qualtrics.com/jfe/form/SV_...
Qualtrics Survey | Qualtrics Experience Management
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
ubc.ca1.qualtrics.com
Don't miss the BMG Research Day happening tomorrow!
Join the 2026 African Pharmacogenomics Network (APN) webinar series 🧬 Considerations for the Development & Implementation of Polygenic Scores in Pharmacogenomics 🎤 Promise co-PI @brittdrog.bsky.social & Dr. Galen Wright 🗓 May 7, 2026 | ⏰ 15:00–16:00 CAT 🔗 Register: lnkd.in/d8F_QZpF #CHRIM #CCMB
🎉 Congratulations to our 2026 Madox’s Warriors Graduated Studentship recipients! 🎉 👏 Paul Layug 👏Helgi Kuzmychova We’re proud to support your journey and celebrate your outstanding achievements! #MadoxsWarriors #GradStudentship #CHRIM #CCMB #CancerResearch
You’re invited! The Madox’s Warriors Graduate Studentship Ceremony takes place on April 22, 2026 (1:00–3:00 PM) at the John Buhler Atrium. Join us as we celebrate this year’s recipients and the impact of supporting pediatric, adolescent, and young adult cancer research. #CHRIM#CCMB#CancerResearch
You’re invited! The Madox’s Warriors Graduate Studentship Ceremony takes place on April 22, 2026 (1:00–3:00 PM) at the John Buhler Atrium. Join us as we celebrate this year’s recipients and the impact of supporting pediatric, adolescent, and young adult cancer research. #CHRIM#CCMB#CancerResearch
PROMISE is honored to attend the 2026 annual meeting of ACCESS& ACCES. Inspired to bring this national effort empowering the childhood cancer community back to Manitoba. #ChildhoodCancer #chrim #ccmb #ayacan #cancerResearch #access
Big congratulations to PROMISE trainee Ovini Amarasinghe, PhD student from #Tremblaylab, on earning the only ECR Oral Presentation Award (Student) at the 2026 New Directions in Leukaemia Research Conference in Adelaide, Australia! 🇨🇦🏆 #CHRIM #CCMB #CanResearch
On April 24, join the Leukemia & Lymphoma Society of Canada for webcast exploring inherited risk, genetic mutations and what emerging research means for you and your patients. www.bloodcancers.ca/events/what-...
What We Know (and Still Don’t Know) About Genes and Blood Cancer
LLSC is the largest voluntary health organization dedicated to funding research, finding cures and ensuring access to treatments for blood cancer patients.
bloodcancers.ca
🚀 We’re live! The official website of PROMISE Research theme is now officially launched! Explore our mission, meet our team, and learn more about our commitment to advancing meaningful, patient-centered research. Together we can, together we will. Visit us at promiseresearch.ca #CCMB #CHRIM #AYACAN
Home - PROMISE
Pediatric Research in Oncology in ManitobannMission: Combine interdisciplinary, fundamental, translational, and clinical research conducted by highly
promiseresearch.ca
ACCESS Presents: Psychosocial Screening Recommendations in Pediatric Cancer Date: Wednesday, February 25, 2026 Time: 12:00 – 1:00 PM ET ca01web.zoom.us/webinar/regi...
Welcome! You are invited to join a webinar: ACCESS Presents: Psychosocial Screening Recommendations in Pediatric Cancer. After registering, you will receive a confirmation email about joining the webi...
Current practice guidelines in pediatric cancer care recommend routine psychosocial screening. However, widespread adoption of systematic screening remains limited, in part due to the large number and...
ca01web.zoom.us
Today is #InternationalChildhoodCancerDay 💛 At PROMISE, we reaffirm our commitment to advancing pediatric cancer research and improving access to high-quality care for children and families across Manitoba. Check out our latest news letter: mailchi.mp/213e78cf908a... #CCMB #CHRIM #AYACancer
PROMISE Monthly News
mailchi.mp
🎉 Publication alert! Congratulations to #PROMISE Co-PI Sapna Oberoi and other co-authors on their new study, A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas, from the Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC).*🔗 link.sosido.com/59f1X9 #CCMB #CHRIM #CancerResearch
A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study
CONCLUSION: Complete resection is critical in CRS. Chemotherapy benefit remains uncertain, underscoring the need for...
link.sosido.com
@cancersociety.bsky.social -funded research is changing how people with #cancer are treated worldwide. We’re proud to see @myesmo.bsky.social #ClinicalPracticeGuideline update recommending structured exercise for people with #ColonCancer. Learn more about this @cctg.bsky.social trial: is.gd/ojV6cY
World-first clinical trial confirms exercise improves survival for colon cancer
A Canadian Cancer Society-funded trial reveals that guided exercise can save and prolong lives by reducing risk of cancer recurrence and second cancers
is.gd
ESMO - European Society for Medical Oncology@myesmo.bsky.social · 6mo ago📣 ESMO #ClinicalPracticeGuideline Express Update on Localised #ColonCancer: 💡CHALLENGE trial suggests survival benefits from structured exercise 👥Selected resected patients to be informed & encouraged to participate #Oncology #ESMOGuidelines 🔗 https://ow.ly/lJY850Y49fR
Today is #WorldCancerDay. We stand with patients, families, researchers, and advocates working toward a future beyond cancer. Grateful to everyone who joined our RIOT & PROMISE Coloring for Awareness event,small actions, shared moments, big impact. #CHRIM #CCMB #CancerResearch
